Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,220.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 1,430.00p
  • 52 Week Low: 430.00p
  • Currency: UK Pounds
  • Shares Issued: 48.79m
  • Volume: 10,384
  • Market Cap: £595.25m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
67.69% above the market average67.69% above the market average67.69% above the market average67.69% above the market average67.69% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
1yr Revenue Growth
70.06% above the market average70.06% above the market average70.06% above the market average70.06% above the market average70.06% above the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
12.02% above the market average12.02% above the market average12.02% above the market average12.02% above the market average12.02% above the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Book Ratio
84.8% below the market average84.8% below the market average84.8% below the market average84.8% below the market average84.8% below the market average
63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
27.72% below the market average27.72% below the market average27.72% below the market average27.72% below the market average27.72% below the market average
1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average
Price Chg 3m
40.62% below the market average40.62% below the market average40.62% below the market average40.62% below the market average40.62% below the market average
1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
6.5% below the market average6.5% below the market average6.5% below the market average6.5% below the market average6.5% below the market average
5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average
Momentum 20
63.48% above the market average63.48% above the market average63.48% above the market average63.48% above the market average63.48% above the market average
64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
35.97% above the market average35.97% above the market average35.97% above the market average35.97% above the market average35.97% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
ROCE
73.51% above the market average73.51% above the market average73.51% above the market average73.51% above the market average73.51% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
70.74% above the market average70.74% above the market average70.74% above the market average70.74% above the market average70.74% above the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Forecast EPS
36.32% above the market average36.32% above the market average36.32% above the market average36.32% above the market average36.32% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
26.07% above the market average26.07% above the market average26.07% above the market average26.07% above the market average26.07% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average
Operating Profit Loss
50.39% above the market average50.39% above the market average50.39% above the market average50.39% above the market average50.39% above the market average
73.08% above the sector average73.08% above the sector average73.08% above the sector average73.08% above the sector average73.08% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
20.27% above the market average20.27% above the market average20.27% above the market average20.27% above the market average20.27% above the market average
26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average26.53% above the sector average
Cash
21.79% above the market average21.79% above the market average21.79% above the market average21.79% above the market average21.79% above the market average
30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
40.44% above the market average40.44% above the market average40.44% above the market average40.44% above the market average40.44% above the market average
Sector averageSector averageSector averageSector averageSector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 1,220.00p
Change Today 5.00p
% Change 0.41 %
52 Week High 1,430.00p
52 Week Low 430.00p
Volume 10,384
Shares Issued 48.79m
Market Cap £595.25m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
97.11% below the market average97.11% below the market average97.11% below the market average97.11% below the market average97.11% below the market average
88.46% below the sector average88.46% below the sector average88.46% below the sector average88.46% below the sector average88.46% below the sector average
Price Trend
85.83% above the market average85.83% above the market average85.83% above the market average85.83% above the market average85.83% above the market average
69.49% above the sector average69.49% above the sector average69.49% above the sector average69.49% above the sector average69.49% above the sector average
Income Not Available
Growth
91.88% above the market average91.88% above the market average91.88% above the market average91.88% above the market average91.88% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 25-Jun-2021

Time Volume / Share Price
11:00 88 @ 1,220.00p
11:00 1 @ 1,220.00p
11:00 207 @ 1,220.00p
11:00 208 @ 1,220.00p
10:54 41 @ 1,219.25p

Ergomed Key Personnel

CFO Richard Barfield

Top of Page